LipidLabs

LipidLabs is a biotechnology company specializing in the design, synthesis, and optimization of lipid nanoparticle (LNP) delivery systems for nucleic acid-based therapeutics. The company provides a comprehensive suite of services, including custom ionizable lipid synthesis, high-throughput LNP formulation screening, and detailed analytical characterization. By leveraging a proprietary library of novel lipids and advanced microfluidic mixing technologies, LipidLabs helps pharmaceutical and biotech partners overcome delivery challenges such as tissue specificity and endosomal escape. Their expertise supports the development of a wide range of genetic medicines, including mRNA vaccines, siRNA-based gene silencing, and CRISPR-based gene editing. LipidLabs operates as a critical technology enabler, accelerating the transition of genomic payloads from early-stage discovery to preclinical proof-of-concept.